Understand Tezepelumab for Chronic Sinusitis Management

June 2026

Tezepelumab (Tezspire) will now be used to manage severe chronic sinusitis with polyps...in addition to severe asthma.

It joins other biologics to manage chronic sinusitis...dupilumab (Dupixent), mepolizumab (Nucala), and omalizumab (Xolair, Omlyclo).

Patients with chronic sinusitis have at least 3 months of congestion, nasal discharge, loss of smell, and facial pressure due to inflammation...NOT due to infection.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Ear, Nose & Throat Be Ready to Help Treat Swimmer’s Ear
UTIs Watch for Antibiotics to Treat Recurrent Bladder Infections
Practice Help Patients Navigate AI Medical Info Safely
Sinusitis Understand Tezepelumab for Chronic Sinusitis Management
Venous Thromboembolism Meds for Pulmonary Embolism: What Pharmacy Techs Should Know
Rumor vs Truth Listen for Questions About Off-Label Uses for Ivermectin
Calculations Make Alligation Calculations as Easy as Tic-Tac-Toe
NatMed Spotlight Sort Out Claims About N-Acetyl Cysteine

Understand Tezepelumab for Chronic Sinusitis Management

Practical advice for a better career, with unlimited access to CE

Table of Contents